🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

6 recruiting trials

for CD30+ Peripheral T-cell Lymphoma

Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas NCT06176690Phase 12 sites📍 Houston📍 Houston Baylor College of Medicine · Tests: C7R.CD30.CAR-EBVST cells Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma NCT04803201Phase 296 sites📍 Little Rock📍 Duarte📍 La Jolla Alliance for Clinical Trials in Oncology · Tests: Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Etoposide CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma NCT04083495Phase 22 sites📍 Chapel Hill📍 Winston-Salem UNC Lineberger Comprehensive Cancer Center · Tests: ATLCAR.CD30 T cells, Bendamustine, Fludarabine, Cyclophosphamide Chidamide Combined With Brentuximab Vedotin Regimen for CD30+ PTCL Patients NCT07074457NA1 site📍 Suzhou The First Affiliated Hospital of Soochow University · Tests: Induction therapy-3 cycles of BvC (Brentuximab vedotin plus Chidamide), Consolidation therapy- 3 or 6 cycles of BvC(Bre… Real-life Experience of Brentuximab Vedotin Plus CHP as First-line Treatment of CD30+ Peripheral T-cell Lymphomas in Spain NCT07624838n/a37 sites📍 A Coruña📍 Palma de Mallorca📍 Palma de Mallorca Grupo Español de Linfomas y Transplante Autólogo de Médula … · Tests: Brentuximab Vedotin Plus CHP Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma NCT05313243Phase 22 sites📍 New Haven📍 Boston Yale University · Tests: Brentuximab vedotin, Pembrolizumab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy